Tivantinib added to erlotinib in nonsmallcell lung cancer: The primary end point was not MET...

G. V. Scagliotti, M. Di Maio

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article numbermdv334
Pages (from-to)2007-2009
Number of pages3
JournalAnnals of Oncology
Issue number10
Publication statusPublished - Oct 1 2015

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this